Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.4295 | 17 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.42462 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42306 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 1.87265 | 2 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64773 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.35604 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.51458 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.40589 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.40168 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.37155 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5504 | 24 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.40304 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.49571 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.41679 | 17 |